Clinical suppression of precocious puberty with cetrorelix after failed treatment with GnRH agonist in a girl with gonadotrophin-independent precocious puberty

Author： Wu Meng-Hsing   Lin Shio-Jean   Wu Li-Hsiang   Cheng Yueh-Chin   Chou Yen-Yin   Pan Hsien-An  

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.11, Iss.1, 2005-07, pp. : 18-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of GnRH antagonists in the treatment of precocious puberty

By Roth Christian  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1253-1259

Informa Healthcare

Access to resources Recommend Favorite

Current pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertainties

By Bertelloni Silvano   Baroncelli Giampiero I  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1627-1639

Informa Healthcare

Access to resources Recommend Favorite

Advances in the treatment of precocious puberty

By Eugster Erica A   Pescovitz Ora H  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1623-1630

Informa Healthcare

Access to resources Recommend Favorite

Central Precocious Puberty: Current Treatment Options

By Franco Antoniazzi   Giorgio Zamboni  

Pediatric Drugs, Vol. 6, Iss. 4, 2004-01 ,pp. : 211-231

Adis International

Access to resources Recommend Favorite

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

By Roulier Roger   Chabert-Orsini Véronique   Sitri Marie-Christine   Barry Bernard   Terriou P  

Reproductive BioMedicine Online, Vol. 7, Iss. 2, 2003-09 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite